Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4008476
Return to Previous Page

Promobanner OCT 2020

4008476

Availability: In stock

4008476

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4008476.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 210.00
CHF 195.30 (7%)
4008476.0025 25 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 840.00
CHF 781.20 (7%)

Details

α-Melanotropin, also known as α-melanocyte-stimulating hormone (α-MSH), is a 13-amino acid peptide originally characterized as a neuropeptide derived from the pituitary gland. α-MSH is synthesized from pro-opiomelanocortin (POMC) by the action of specific prohormone convertases and is involved in the regulation of important physiological functions including food intake, energy homeostasis, modulation of immune responses and photoprotection.
Catalog Number H-1075
APC Number 56-1-11
One Letter Code Ac-SYSMEHFRWGKPV-NH₂
Synonyms α-Melanotropin (human), Acetyl-ACTH (1-13) amide
Molecular Formula C₇₇H₁₀₉N₂₁O₁₉S
Relative Molecular Mass 1664.91
CAS Registry Number 581-05-5
Source Synthetic
Storage Conditions -20 ± 5 °C
Application Pituitary & Hypothalamic Hormones
Links / Documents:

Bachem product citations

C.L.Moller et al., PLoS One, 11, e0157027 (2016)
E.Raffan et al., Cell Metab., 23, 893 (2016)
N.Tennoune et al., Nutrition, 31, 498 (2015)
D.Y.Lewitus et al., J. Appl. Polym. Sci., 131, (2014)
A.I.Martin et al., Mediators Inflamm., 2014, 179368 (2014)
G.S.Liu et al., Free Radic. Biol. Med., 70, 14 (2014)
N.Tennoune et al., Transl. Psychiatry, 4, e458 (2014)
R.Cortes et al., Gen. Comp. Endocrinol., 201, 30 (2014)
S.Veiksina et al., Biochim. Biophys. Acta, 1838, 372 (2014)
W.T.Weng et al., Biochim. Biophys. Acta, 1840, 1850 (2014)
B.J.Renquist et al., Zebrafish, 10, 343 (2013)
F.R.Temp et al., Life Sci., 93, 723 (2013)
Q.Coquerel et al., Psychoneuroendocrinology, 37, 94 (2012)
A.W.Taylor and D.J.Lee, J. Transplant., 2011, 246856 (2011)
D.Zegers et al., Obesity (Silver Spring), 19, 152 (2011)
F.Verrier et al., Nat. Chem. Biol., 7, 909 (2011)
H.R.Sobhi et al., J. Chromatogr. A., 1218, 8536 (2011)
M.W.Gardner and J.S.Brodbelt, Anal. Chem., 82, 5751 (2010)
N.Santoro et al., BMC Med. Genet., 10, 25 (2009)
N.Santoro et al., BMC Med. Genet., 10, 25 (2009)
A.Nesterov et al., Chem. Pharm. Bull. (Tokyo), 56, 1292 (2008)
A.W.Taylor and N.Kitaichi, Brain Behav. Immun., 22, 639 (2008)
D.Li and A.W.Taylor, J. Leukoc. Biol., 84, 191 (2008)
M.Charnley et al., Peptides, 29, 1004 (2008)
M.W.Gardner et al., Anal. Chem., 80, 4807 (2008)
S.C.Harmer et al., J. Endocrinol., 196, 149 (2008)
J.D.Spencer et al., J. Invest. Dermatol., 127, 411 (2007)
E.U.Do et al., Biochem. Biophys. Res. Commun., 343, 1094 (2006)
G.Cai et al., Obesity (Silver Spring), 14, 1596 (2006)
H.B.Schioth et al., Basic Clin. Pharmacol. Toxicol., 99, 287 (2006)
J.Menyhert et al., Brain Res., 1076, 101 (2006)
L.Zvejniece et al., Pharmacol. Biochem. Behav., 85, 287 (2006)
Z.Xiang et al., Biochemistry, 45, 7277 (2006)
C.E.de Rijke et al., Biochem. Pharmacol., 70, 308 (2005)
C.Lindberg et al., Neurotox. Res., 8, 267 (2005)
M.J.Kas et al., J. Mol. Endocrinol., 35, 159 (2005)
R.L.Bradley et al., Obes. Res., 13, 653 (2005)
T.A.Czyzyk et al., Dev. Biol., 287, 301 (2005)
Z.Marinova et al., Biochem. Biophys. Res. Commun., 321, 202 (2004)
I.S.Farooqi et al., N. Engl. J. Med., 348, 1085 (2003)
S.A.Stanley et al., FEBS Lett., 543, 66 (2003)
S.J.Getting et al., J. Pharmacol. Exp. Ther., 306, 631 (2003)
M.Moustafa et al., J. Invest. Dermatol., 119, 1244 (2002)
I.S.Farooqi et al., J. Clin. Invest., 106, 271 (2000)
M.Szardenings et al., Peptides, 21, 239 (2000)
P.K.Garg et al., Bioconjug. Chem., 7, 233 (1996)

4008476

Enzyme Substrates Inhibitors
Neurolysin